Duration of Effect of Alipogene Tiparvovec Treatment, Which Was Administered in Other Studies

NCT01447901 · clinicaltrials.gov ↗

TERMINATED

Status

19

Enrollment

INDUSTRY

Sponsor class

Stopped Business reason

Conditions

Hyperlipoproteinemia Type I

Sponsor

Amsterdam Molecular Therapeutics

Collaborators

[object Object]